OncoMed Pharmaceuticals, Inc.
     
 
 

Financial Information

Here you will find a summary of OncoMed Pharmaceuticals's latest financial information.

Latest Earnings Release and 10-Q Date Filed Format Size  
Second Quarter Financial Results HTML file N/A  
Form 10-Q Aug 2, 2017 HTML file  PDF file   View XBRL 405.1 KB Add to Briefcase
Form 10-Q May 8, 2017 HTML file  PDF file   View XBRL 373.0 KB Add to Briefcase
 
Latest Annual Report and 10-K Date Filed Format Size  
2016 Annual Report   PDF 1.1 MB Add to Briefcase
Form 10-K Mar 9, 2017 HTML file  PDF file   View XBRL 1.1 MB Add to Briefcase
 
Latest Proxy Statement Date Filed Format Size  
Proxy Statement (DEFA14A) Apr 13, 2017 HTML file  PDF file 314.7 KB Add to Briefcase
Proxy Statement Apr 13, 2017 HTML file  PDF file 539.5 KB Add to Briefcase
Add to Briefcase = add PDF file to Briefcase
Stock Quote (NASDAQ: OMED)
Price:
4.31
Change:
0.00
Day High:
N/A
Day Low:
N/A
Volume:
N/A
4:00 PM ET on Aug 17, 2017
Delayed at least 20 minutes.
Provided by eSignal.
Search Investor Relations